Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Hematology/Oncology Clinics of North America|October 25, 2020
Options for Chemotherapy and Scoring Response and RelapseCindy Varga, Chakra ChaulagainAnnals of Translational Medicine|November 7, 2024
How we manage multiple myeloma with clonal hematopoiesis of indeterminate potential (CHIP): a case reportLudovic Saba, Lewis Nasr, Jorge Manrique-Succar, et al.Blood|April 12, 2014
One siRNA pool targeting the λ constant region stops λ light-chain production and causes terminal endoplasmic reticulum stressPing Zhou, Xun Ma, Lakshmanan Iyer, et al.Leukemia & Lymphoma|March 13, 2021
Early mortality and overall survival in acute promyelocytic leukemia: do real-world data match results of the clinical trials?Prajwal Dhakal, Elizabeth Lyden, Venkat Rajasurya, et al.Leukemia & Lymphoma|November 18, 2021
Determinants of ten-year overall survival of acute myeloid leukemia: a large national cancer database analysisNabin Khanal, Valerie Shostrom, Prajwal Dhakal, et al.Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|June 6, 2023
Risk of Venous Thromboembolism in Multiple Myeloma Patients During the Immediate Peri-Autologous Hematopoietic Cell Transplantation PhaseHussein Awada, Adel Hajj Ali, Faiz Anwer, et al.Cancers|April 13, 2023
Management of Relapsed-Refractory Multiple Myeloma in the Era of Advanced Therapies: Evidence-Based Recommendations for Routine Clinical PracticeDanai Dima, Fauzia Ullah, Sandra Mazzoni, et al.Blood Reviews|May 17, 2025
Suppression to removal, an emerging therapeutic approach for AL amyloidosis: A comprehensive review with early human data and pharmacokinetics of CAEL-101 antibodyAnam Ashfaque, Yara Shatnawi, Shahzad Raza, et al.Blood Reviews|September 11, 2019
Treatment of relapsed multiple myeloma: Evidence-based recommendationsCeren Durer, Seren Durer, Sarah Lee, et al.Cardio-Oncology (London, England)|July 22, 2020
Practical and cost-effective model to build and sustain a cardio-oncology programDiego Sadler, Chakra Chaulagain, Beatrice Alvarado, et al.Pageof 2